Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-01-17 Sale |
2023-01-18 8:29 pm |
Mersana Therapeutics Inc. | MRSN | Yang Arvin SVP, Chief Medical Officer |
2,209 | $5.74 | $12,680 | 317,903 (Direct) |
View |
| 2023-01-17 Sale |
2023-01-18 8:24 pm |
Mersana Therapeutics Inc. | MRSN | Protopapas Anna President & CEO |
17,346 | $5.74 | $99,566 | 1,159,198 (Indirect Direct) |
View |
| 2023-01-17 Sale |
2023-01-18 8:20 pm |
Mersana Therapeutics Inc. | MRSN | Mandelia Ashish VP, Controller |
3,575 | $5.74 | $20,521 | 96,047 (Direct) |
View |
| 2023-01-17 Sale |
2023-01-18 8:18 pm |
Mersana Therapeutics Inc. | MRSN | MISRA TUSHAR SVP, CMO |
458 | $5.74 | $2,629 | 166,137 (Direct) |
View |
| 2023-01-17 Sale |
2023-01-18 8:14 pm |
Mersana Therapeutics Inc. | MRSN | Lowinger Timothy B SVP, Chief Sci.&Tech. Off. |
6,233 | $5.74 | $35,777 | 423,487 (Direct) |
View |
| 2023-01-17 Sale |
2023-01-18 8:12 pm |
Mersana Therapeutics Inc. | MRSN | DeSchuytner Brian SVP, Chief Financial Officer |
5,131 | $5.74 | $29,452 | 287,989 (Direct) |
View |
| 2023-01-17 Sale |
2023-01-18 8:09 pm |
Mersana Therapeutics Inc. | MRSN | Carvajal Alejandra SVP, Chief Legal Officer |
782 | $5.74 | $4,489 | 215,603 (Direct) |
View |
| 2022-12-01 Sale |
2022-12-02 4:01 pm |
Mersana Therapeutics Inc. | MRSN | Yang Arvin Chief Medical Officer |
5,527 | $6.59 | $36,423 | 25,946 (Direct) |
View |
| 2022-08-17 Sale |
2022-08-18 4:40 pm |
Mersana Therapeutics Inc. | MRSN | MISRA TUSHAR Chief Manufacturing Officer |
1,879 | $7.1 | $13,341 | 23,121 (Direct) |
View |
| 2022-05-31 Purchase |
2022-06-02 6:17 pm |
Mersana Therapeutics Inc. | MRSN | Hack Andrew A. F. Director |
95,519 | $3.2659 | $311,958 | 8,663,673 (Indirect) |
View |
| 2022-05-24 Purchase |
2022-05-26 6:02 pm |
Mersana Therapeutics Inc. | MRSN | Hack Andrew A. F. Director |
265,155 | $3.2214 | $854,175 | 8,568,154 (Indirect) |
View |
| 2022-05-19 Purchase |
2022-05-23 5:49 pm |
Mersana Therapeutics Inc. | MRSN | Hack Andrew A. F. Director |
215,599 | $3.4622 | $746,437 | 8,302,999 (Indirect) |
View |
| 2022-05-16 Purchase |
2022-05-18 6:19 pm |
Mersana Therapeutics Inc. | MRSN | Hack Andrew A. F. Director |
350,000 | $3.2505 | $1,137,660 | 8,087,400 (Indirect) |
View |
| 2022-04-26 Sale |
2022-04-28 5:23 pm |
Mersana Therapeutics Inc. | MRSN | Carvajal Alejandra Chief Legal Officer |
3,948 | $3.69 | $14,568 | 22,552 (Direct) |
View |
| 2022-04-13 Purchase |
2022-04-14 4:59 pm |
Mersana Therapeutics Inc. | MRSN | Hack Andrew A. F. Director |
617,284 | $4.05 | $2,500,000 | 7,737,400 (Indirect) |
View |
| 2022-04-12 Purchase |
2022-04-13 6:27 pm |
Mersana Therapeutics Inc. | MRSN | Hack Andrew A. F. Director |
598,086 | $4.1798 | $2,499,880 | 7,120,116 (Indirect) |
View |
| 2022-02-07 Purchase |
2022-02-08 5:04 pm |
Mersana Therapeutics Inc. | MRSN | Hack Andrew A. F. Director |
1,136,363 | $4.42 | $5,022,724 | 6,522,030 (Indirect) |
View |
| 2022-01-18 Sale |
2022-01-19 6:25 pm |
Mersana Therapeutics Inc. | MRSN | Lowinger Timothy B Chief Science & Tech Off. |
4,741 | $5.92 | $28,067 | 274,359 (Direct) |
View |
| 2022-01-18 Sale |
2022-01-19 6:19 pm |
Mersana Therapeutics Inc. | MRSN | Mandelia Ashish VP, Controller |
1,982 | $5.92 | $11,733 | 66,427 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-04-03 Option Award |
2023-04-05 5:15 pm |
N/A 2033-04-02 |
Mersana Therapeutics Inc. | MRSN | Hege Kristen Director |
3,451 | $0 | 3,451 (Direct) |
View |
| 2023-04-03 Option Award |
2023-04-05 5:15 pm |
N/A 2033-04-02 |
Mersana Therapeutics Inc. | MRSN | Huber Martin H. Jr. Director |
3,375 | $0 | 3,375 (Direct) |
View |
| 2023-04-03 Option Award |
2023-04-05 5:14 pm |
N/A N/A |
Mersana Therapeutics Inc. | MRSN | MOTT DAVID M Director |
4,866 | $0 | 553,060 (Direct) |
View |
| 2023-04-03 Option Award |
2023-04-05 5:14 pm |
N/A 2033-04-02 |
Mersana Therapeutics Inc. | MRSN | Alleva Lawrence M Director |
4,525 | $0 | 4,525 (Direct) |
View |
| 2023-04-03 Option Award |
2023-04-05 5:12 pm |
N/A N/A |
Mersana Therapeutics Inc. | MRSN | Dere Willard H Director |
3,375 | $0 | 3,375 (Direct) |
View |
| 2023-01-14 Exercise |
2023-01-18 8:29 pm |
N/A N/A |
Mersana Therapeutics Inc. | MRSN | Yang Arvin SVP, Chief Medical Officer |
7,084 | $0 | 317,903 (Direct) |
View |
| 2023-01-13 Option Award |
2023-01-18 8:29 pm |
N/A 2033-01-12 |
Mersana Therapeutics Inc. | MRSN | Yang Arvin SVP, Chief Medical Officer |
265,833 | $0 | 317,903 (Direct) |
View |
| 2023-01-14 Exercise |
2023-01-18 8:24 pm |
N/A N/A |
Mersana Therapeutics Inc. | MRSN | Protopapas Anna President & CEO |
55,708 | $0 | 1,159,198 (Direct) |
View |
| 2023-01-13 Option Award |
2023-01-18 8:24 pm |
N/A 2033-01-12 |
Mersana Therapeutics Inc. | MRSN | Protopapas Anna President & CEO |
687,500 | $0 | 1,159,198 (Direct) |
View |
| 2022-05-20 Gift |
2023-01-18 8:24 pm |
N/A N/A |
Mersana Therapeutics Inc. | MRSN | Protopapas Anna President & CEO |
240,244 | $0 | 1,159,198 (Direct) |
View |
| 2023-01-14 Exercise |
2023-01-18 8:20 pm |
N/A N/A |
Mersana Therapeutics Inc. | MRSN | Mandelia Ashish VP, Controller |
10,136 | $0 | 96,047 (Direct) |
View |
| 2023-01-13 Option Award |
2023-01-18 8:20 pm |
N/A 2033-01-12 |
Mersana Therapeutics Inc. | MRSN | Mandelia Ashish VP, Controller |
58,208 | $0 | 96,047 (Direct) |
View |
| 2023-01-14 Exercise |
2023-01-18 8:18 pm |
N/A N/A |
Mersana Therapeutics Inc. | MRSN | MISRA TUSHAR SVP, CMO |
1,459 | $0 | 166,137 (Direct) |
View |
| 2023-01-13 Option Award |
2023-01-18 8:18 pm |
N/A 2033-01-12 |
Mersana Therapeutics Inc. | MRSN | MISRA TUSHAR SVP, CMO |
155,833 | $0 | 166,137 (Direct) |
View |
| 2023-01-14 Exercise |
2023-01-18 8:14 pm |
N/A N/A |
Mersana Therapeutics Inc. | MRSN | Lowinger Timothy B SVP, Chief Sci.&Tech. Off. |
20,001 | $0 | 423,487 (Direct) |
View |
| 2023-01-13 Option Award |
2023-01-18 8:14 pm |
N/A 2033-01-12 |
Mersana Therapeutics Inc. | MRSN | Lowinger Timothy B SVP, Chief Sci.&Tech. Off. |
206,250 | $0 | 423,487 (Direct) |
View |
| 2023-01-14 Exercise |
2023-01-18 8:12 pm |
N/A N/A |
Mersana Therapeutics Inc. | MRSN | DeSchuytner Brian SVP, Chief Financial Officer |
16,458 | $0 | 287,989 (Direct) |
View |
| 2023-01-13 Option Award |
2023-01-18 8:12 pm |
N/A 2033-01-12 |
Mersana Therapeutics Inc. | MRSN | DeSchuytner Brian SVP, Chief Financial Officer |
220,000 | $0 | 287,989 (Direct) |
View |
| 2023-01-14 Exercise |
2023-01-18 8:09 pm |
N/A N/A |
Mersana Therapeutics Inc. | MRSN | Carvajal Alejandra SVP, Chief Legal Officer |
2,500 | $0 | 215,603 (Direct) |
View |
| 2023-01-13 Option Award |
2023-01-18 8:09 pm |
N/A 2033-01-12 |
Mersana Therapeutics Inc. | MRSN | Carvajal Alejandra SVP, Chief Legal Officer |
197,083 | $0 | 215,603 (Direct) |
View |
| 2022-12-14 Exercise |
2022-12-16 4:46 pm |
N/A 2024-01-09 |
Mersana Therapeutics Inc. | MRSN | Lowinger Timothy B SVP, Chief Sci.&Tech. Off. |
35,361 | $0 | 270,463 (Direct) |
View |
| 2022-12-14 Exercise |
2022-12-16 4:46 pm |
N/A N/A |
Mersana Therapeutics Inc. | MRSN | Lowinger Timothy B SVP, Chief Sci.&Tech. Off. |
11,111 | $1.4 | 270,463 (Direct) |
View |
| 2022-12-14 Exercise |
2022-12-16 4:46 pm |
N/A N/A |
Mersana Therapeutics Inc. | MRSN | Lowinger Timothy B SVP, Chief Sci.&Tech. Off. |
24,250 | $1.53 | 270,463 (Direct) |
View |
| 2022-11-30 Exercise |
2022-12-02 4:01 pm |
N/A N/A |
Mersana Therapeutics Inc. | MRSN | Yang Arvin Chief Medical Officer |
18,500 | $0 | 25,946 (Direct) |
View |
| 2022-08-16 Exercise |
2022-08-18 4:40 pm |
N/A N/A |
Mersana Therapeutics Inc. | MRSN | MISRA TUSHAR Chief Manufacturing Officer |
6,250 | $0 | 23,121 (Direct) |
View |
| 2022-06-09 Option Award |
2022-06-10 5:25 pm |
N/A 2032-06-08 |
Mersana Therapeutics Inc. | MRSN | Hack Andrew A. F. Director |
45,000 | $0 | 45,000 (Direct) |
View |
| 2022-06-09 Option Award |
2022-06-10 4:21 pm |
N/A 2032-06-08 |
Mersana Therapeutics Inc. | MRSN | Alleva Lawrence M Director |
45,000 | $0 | 45,000 (Direct) |
View |
| 2022-06-09 Option Award |
2022-06-10 4:20 pm |
N/A 2032-06-08 |
Mersana Therapeutics Inc. | MRSN | Dere Willard H Director |
45,000 | $0 | 45,000 (Direct) |
View |
| 2022-06-09 Option Award |
2022-06-10 4:19 pm |
N/A 2032-06-08 |
Mersana Therapeutics Inc. | MRSN | Diaz Allene M. Director |
45,000 | $0 | 45,000 (Direct) |
View |
| 2022-06-09 Option Award |
2022-06-10 4:19 pm |
N/A 2032-06-08 |
Mersana Therapeutics Inc. | MRSN | MOTT DAVID M Director |
45,000 | $0 | 45,000 (Direct) |
View |
| 2022-06-09 Option Award |
2022-06-10 4:18 pm |
N/A 2032-06-08 |
Mersana Therapeutics Inc. | MRSN | Huber Martin H. Jr. Director |
45,000 | $0 | 45,000 (Direct) |
View |
| 2022-06-09 Option Award |
2022-06-10 4:17 pm |
N/A 2032-06-08 |
Mersana Therapeutics Inc. | MRSN | Hege Kristen Director |
45,000 | $0 | 45,000 (Direct) |
View |
| 2022-04-26 Exercise |
2022-04-28 5:23 pm |
N/A N/A |
Mersana Therapeutics Inc. | MRSN | Carvajal Alejandra Chief Legal Officer |
13,250 | $0 | 22,552 (Direct) |
View |
| 2022-01-14 Exercise |
2022-01-19 6:25 pm |
N/A N/A |
Mersana Therapeutics Inc. | MRSN | Lowinger Timothy B Chief Science & Tech Off. |
30,418 | $0 | 274,359 (Direct) |
View |
| 2022-01-14 Option Award |
2022-01-19 6:25 pm |
N/A 2032-01-13 |
Mersana Therapeutics Inc. | MRSN | Lowinger Timothy B Chief Science & Tech Off. |
105,417 | $0 | 274,359 (Direct) |
View |
| 2022-01-14 Exercise |
2022-01-19 6:19 pm |
N/A N/A |
Mersana Therapeutics Inc. | MRSN | Mandelia Ashish VP, Controller |
10,706 | $0 | 66,427 (Direct) |
View |
| 2022-01-14 Option Award |
2022-01-19 6:19 pm |
N/A 2032-01-13 |
Mersana Therapeutics Inc. | MRSN | Mandelia Ashish VP, Controller |
47,833 | $0 | 66,427 (Direct) |
View |
| 2022-01-14 Option Award |
2022-01-19 6:03 pm |
N/A 2032-01-13 |
Mersana Therapeutics Inc. | MRSN | MISRA TUSHAR Chief Manufacturing Officer |
32,083 | $0 | 32,083 (Direct) |
View |
| 2022-01-14 Exercise |
2022-01-19 6:01 pm |
N/A N/A |
Mersana Therapeutics Inc. | MRSN | Protopapas Anna President & CEO |
77,916 | $0 | 790,494 (Direct) |
View |
| 2022-01-14 Option Award |
2022-01-19 6:01 pm |
N/A 2032-01-13 |
Mersana Therapeutics Inc. | MRSN | Protopapas Anna President & CEO |
368,450 | $0 | 790,494 (Direct) |
View |
| 2022-01-14 Option Award |
2022-01-19 5:59 pm |
N/A 2032-01-13 |
Mersana Therapeutics Inc. | MRSN | Yang Arvin Chief Medical Officer |
155,833 | $0 | 168,806 (Direct) |
View |
| 2022-01-14 Exercise |
2022-01-19 5:45 pm |
N/A N/A |
Mersana Therapeutics Inc. | MRSN | DeSchuytner Brian Chief Financial Officer |
20,416 | $0 | 181,739 (Direct) |
View |
| 2022-01-14 Option Award |
2022-01-19 5:45 pm |
N/A 2032-01-13 |
Mersana Therapeutics Inc. | MRSN | DeSchuytner Brian Chief Financial Officer |
137,500 | $0 | 181,739 (Direct) |
View |
| 2022-01-14 Option Award |
2022-01-19 5:43 pm |
N/A 2032-01-13 |
Mersana Therapeutics Inc. | MRSN | Carvajal Alejandra Chief Legal Officer |
55,000 | $0 | 55,000 (Direct) |
View |
| 2022-01-03 Option Award |
2022-01-05 6:47 pm |
N/A 2032-01-02 |
Mersana Therapeutics Inc. | MRSN | Hack Andrew A. F. Director |
10,995 | $0 | 10,995 (Direct) |
View |
| 2022-01-03 Option Award |
2022-01-05 5:07 pm |
N/A 2032-01-02 |
Mersana Therapeutics Inc. | MRSN | MOTT DAVID M Director |
18,518 | $0 | 18,518 (Direct) |
View |
| 2022-01-03 Option Award |
2022-01-05 5:05 pm |
N/A 2032-01-02 |
Mersana Therapeutics Inc. | MRSN | Huber Martin H. Jr. Director |
10,185 | $0 | 10,185 (Direct) |
View |